BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 34.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 20,720 shares of the medical equipment provider’s stock after purchasing an additional 5,358 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Intuitive Surgical were worth $21,671,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Stifel Financial Corp increased its position in Intuitive Surgical by 11.2% in the 2nd quarter. Stifel Financial Corp now owns 8,356 shares of the medical equipment provider’s stock valued at $7,837,000 after acquiring an additional 841 shares during the period. Keybank National Association OH increased its position in Intuitive Surgical by 26.7% in the 2nd quarter. Keybank National Association OH now owns 1,322 shares of the medical equipment provider’s stock valued at $1,237,000 after acquiring an additional 279 shares during the period. First Trust Advisors LP increased its position in Intuitive Surgical by 61.4% in the 3rd quarter. First Trust Advisors LP now owns 51,130 shares of the medical equipment provider’s stock valued at $53,476,000 after acquiring an additional 19,458 shares during the period. Davis R M Inc. acquired a new position in Intuitive Surgical in the 3rd quarter valued at about $219,000. Finally, TIAA CREF Investment Management LLC increased its position in Intuitive Surgical by 9.8% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 449,917 shares of the medical equipment provider’s stock valued at $420,839,000 after acquiring an additional 40,115 shares during the period. Institutional investors and hedge funds own 32.80% of the company’s stock.
In related news, Director Alan J. Levy sold 2,997 shares of the company’s stock in a transaction that occurred on Tuesday, October 24th. The stock was sold at an average price of $371.35, for a total value of $1,112,935.95. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Curet Myriam sold 262 shares of the company’s stock in a transaction that occurred on Tuesday, October 24th. The shares were sold at an average price of $373.00, for a total value of $97,726.00. The disclosure for this sale can be found here. Insiders have sold a total of 55,944 shares of company stock worth $21,432,971 in the last three months. Corporate insiders own 2.20% of the company’s stock.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.99 by $0.78. The business had revenue of $806.10 million for the quarter, compared to analyst estimates of $753.25 million. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. The company’s quarterly revenue was up 18.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.06 EPS. equities research analysts anticipate that Intuitive Surgical, Inc. will post 7.85 earnings per share for the current fiscal year.
Several equities analysts recently issued reports on ISRG shares. Wedbush restated a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday, October 10th. Goldman Sachs Group reiterated a “buy” rating on shares of Intuitive Surgical in a research report on Saturday, November 18th. Morgan Stanley reiterated an “overweight” rating on shares of Intuitive Surgical in a research report on Tuesday, September 5th. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 target price on the stock in a research report on Tuesday, December 12th. Finally, Barclays reiterated an “overweight” rating on shares of Intuitive Surgical in a research report on Friday, October 20th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the stock. Intuitive Surgical currently has a consensus rating of “Buy” and a consensus price target of $335.32.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Week Herald and is the property of of Week Herald. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://weekherald.com/2017/12/30/british-columbia-investment-management-corp-buys-5358-shares-of-intuitive-surgical-inc-isrg.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.